JNJ-42165279
id:
jnj-42165279-286-6793299
title:
JNJ-42165279
text:
JNJ-42165279 is a drug developed by Janssen Pharmaceutica which acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), with an IC50 of 70 nM. It is described as a covalently binding but slowly reversible selective inhibitor of FAAH. JNJ-42165279 is being developed for the treatment of anxiety disorders and major depressive disorder. Clinical development has progressed as far as Phase II human trials with two studies in patients with mood disorders registered in
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/JNJ-42165279
date created:
date modified:
2022-04-13T03:38:46Z
main entity:
{"identifier":"Q25101230","url":"https://www.wikidata.org/entity/Q25101230"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8a/JNJ-42165279_Structure.svg","width":512,"height":172}
fields total:
13
integrity:
15